(25 May 2021) Plitidepsin- discharge rates by Days 8 and 15 were 56.8% and 81.8%
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization https://www.medrxiv.org/content/10.1101/2021.05.25.21257505v1 EudraCT #2020-001993-31 NCT #04382066- Plitidepsin is a marine-derived cyclic-peptide that inhibits SARS-CoV-2 replication at low nanomolar concentrations by the targeting of host protein eEF1A (eukaryotic translation-elongation-factor-1A).… Continue reading "(25 May 2021) Plitidepsin- discharge rates by Days 8 and 15 were 56.8% and 81.8%"